|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 2.110 USD | -0.94% |
|
-1.86% | -26.74% |
EPS & Dividend: Processa Pharmaceuticals, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1,269 | -373 | -851.2 | -212 | -96.82 | -10.36 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 3,297.500 | 2,450.000 | 550.000 | 167.300 | 22.095 | 2.880 |
| Nbr of stocks (in thousands) | 21.1 | 31.4 | 32 | 49.3 | 131 | 2,266 |
| Announcement Date | 3/25/21 | 3/30/22 | 3/30/23 | 3/29/24 | 3/20/25 | 3/18/26 |
1USD in Million2USD
Estimates
Past dividends: Processa Pharmaceuticals, Inc.
| 2025-12-17 | Significant Split/Dividend | 00:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.41% | 1.58% | 20.97x | 4.92x | 7.35x | |
| 0.04% | 0.08% | 37.32x | 7.78x | 9.68x | |
| -.--% | -.--% | -17.15x | 1.39x | 7.14x | |
| -.--% | -.--% | 30.86x | 3.26x | 6.62x | |
| -.--% | -.--% | -78.62x | 38.1x | 14.69x | |
| -.--% | -.--% | 27.31x | 3.25x | 5.12x | |
| 0.25% | 0.15% | 59.78x | 14.88x | 22.25x | |
| -.--% | -.--% | 1692.68x | 18.36x | 39.78x | |
| -.--% | -.--% | 17.35x | 5.34x | 5.16x | |
| Average | 0.19% | 0.2% | 198.94x | 10.81x | 13.09x | |
| Weighted average by Cap. | 0.37% | 0.41% | 107.54x | 9.55x | 11.07x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
